On Thursday (January 18) a cannabis operator trading in Canada but focused in the US market strengthened its efforts in Florida, where investors could see a race for the market share heating up.
iAnthus Capital Holdings (CSE:IAN; OTCQB:ITHUF) announced it acquired the assets of GrowHealthy Holdings a local Florida company formed in 2014, which includes its affiliate McCrory’s Sunny Hill Nursery that holds one out of the 13 current Florida Medical Marijuana Treatment Centers.
“The state’s population includes a large percentage of older adults who can derive significant benefits from medical cannabis,” Randy Maslow, president of iAnthus said in the announcement.
The company explained to shareholders it paid $17.5 million in cash and “$30,500,000 was satisfied in iAnthus common shares at a price per share of $2.52.”
The cannabis producer won’t be getting a finished facility. Rather, the company will complete it with its own resources and is promising a 200,000 square feet cultivation space capable of producing 18,000 kilograms of cannabis flower per year once completed. No timetable was given for the completion of this facility.
“The GrowHealthy cultivation and operations team has already established itself as a leader in Florida’s medical cannabis market, and we look forward to contributing iAnthus’ capital and operational resources to fully build out GrowHealthy’s infrastructure,” Maslow said.
Competition brews in Florida for medical cannabis market control
One of the current leaders in the state of Florida, as far as public players focused on medical cannabis, is Liberty Health Sciences (CSE:LHS; OTCQX:LHSIF). This company launched last year with the backup from one of the major Licensed Producers (LPs) in Canada, Aphria (TSX:APH; OTC:APHQF).
Liberty Health recently opened its inaugural dispensary in the state, where a retirement community was specifically placed. Liberty Health expects to open another Florida location in the early part of 2018, increasing its sites to five.
Companies trading in Canadian exchanges but focusing on the American market or even holding direct interests there have faced scrutiny over the legality of this particular situation.
Most famously last year the TMX Group, which sees over the Toronto Stock Exchange (TSX) and the TSXV Ventures Exchange, issued a warning to publicly listed companies operating with aspirations in the US.
While the year is still young, shares for iAnthus have steadily been increasing in value. value steadily this year. So far in 2018, the company’s share price has gone up 52 percent. However, by market close on Thursday the company’s share price dropped 3.55 percent.
For Liberty Health, its share price has been trending downwards. Year-to-date, its share price has declined 14.49 percent. The entire cannabis market suffered a big blow after US Attorney General Jeff Sessions rescinded the Cole Memo, a guidance for cannabis businesses in the country protecting them from federal persecution.
That said, shares of Liberty Health have increased in value 28.26 since launching on the Canadian Securities Exchange last year.
As the cannabis market in the US begins to develop it’s key to watch closely the development of areas of interest like Nevada and California, where public companies are facing one another and competing with local businesses. According to data from Arcview Market Research, as shared by iAnthus, the Florida medical cannabis market is expected to reach a billion dollars by 2020.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/